BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2002
View Archived Issues
New data on the efficacy and safety of valdecoxib
Read More
ABI-007 trial cleared to continue
Read More
Novel antifungal compound SF-2822 described by Meiji Seika researchers
Read More
Sankyo patents new antibacterial agents isolated from Streptomyces cultures
Read More
Antifungal cyclic peptides prepared and tested at Takara Shuzo
Read More
Cell Therapeutics presents new inhibitors of IL-12 and IL-4 signaling for asthma, diabetes, etc.
Read More
New DPP-IV inhibitors in early development at Boehringer Ingelheim
Read More
Toyama presents novel agents with neuroprotective and neurotrophic activity
Read More
Banyu describes novel compounds able to increase GLP-1 levels
Read More
Keryx extends international manufacturing and negotiating rights for KRX-101
Read More
CollaGenex signs copromotion deal with Novartis for Denavir
Read More
Saegis licenses preclinical compound from Lilly for cognitive impairment
Read More
British Biotech and Serono extend antiinflammatory research agreement
Read More
First of three pivotal phase III trials of AC-2993 in type 2 diabetes completes enrollment
Read More
Inhibition of p38 MAP kinase associated with significant antiinflammatory effects in CIA
Read More
Two Genzyme enzyme replacement therapies up for FDA panel review in January
Read More
Pascolizumab characterized preclinically prior to clinical studies
Read More
Octapeptide based on alpha-MSH combines both antiinflammatory and antiinfective properties
Read More
Further development of LY-333531 for diabetic neuropathy and vasculopathy warranted
Read More
Potent and gut-selective Ca2+ channel antagonist with potential in IBS
Read More
GSK and Biosynexus to develop and commercialize staphylococcal antibodies and vaccines
Read More
Phase III Provenge trial resumes enrollment
Read More
Second Allox phase I/II trial completed
Read More
Chiron announces discontinuation of various programs
Read More
Cerebril phase II IND cleared
Read More
COGNIShunt system receives European regulatory approval
Read More
Statin induces apoptosis in RA synoviocytes
Read More